4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-25-015322
President and CEO sold 9,896 shares at $57.22 ($566,249)
- President and CEO acquired 21,250 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Meeker David P President and CEO | 2025-02-16 | Option exercise 10b5-1 | +21,250 | 211,177 | D | ||
| Meeker David P President and CEO | 2025-02-19 | Sale 10b5-1 | −9,896 | $57.22 | $566,249 | 201,281 | D |
| Derivatives | |||||||
| Meeker David P President and CEO | 2025-02-14 | Grant or award · Restricted Stock Units 10b5-1 | +133,350 | 133,350 | D | ||
| Meeker David P President and CEO | 2025-02-14 | Grant or award · Stock Options (Right to Buy) 10b5-1 | +200,000 | 200,000 | D | ||
| Meeker David P President and CEO | 2025-02-16 | Option exercise · Restricted Stock Units 10b5-1 | −21,250 | 63,750 | D | ||
| Open-market sales · 9,896 sh · avg $57.22 · $566,249 | |||||||
Loading xslF345X05/tm257103-6_4seq1.xml…